MedPath

Safety and efficacy of Ketoconazole in Combination With Beclomethasone

Phase 4
Completed
Conditions
Health Condition 1: null- Patients With Tinea Infections
Registration Number
CTRI/2018/02/011935
Lead Sponsor
Med Manor Organics Pvt ltd
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
30
Inclusion Criteria

1.Subjects with tinea infections who are either treatment naive or were not on any treatment for at-least 3 months

2.Have a clinical diagnosis of uncomplicated interdigital Tinea pedis confirmed by KOH microscopy

3.Subjects aged 12 to 75 years with Tinea Infections

4.Subjects with Epidermal type of Tinea infections

5.Subjects willing to return for all clinic visits and complete all study-related procedures

Exclusion Criteria

1.Subjects with dermal or any other type of fungal infections other than epidermal type

2.Subjects who are either pregnant or breast feeding

3.Have a previous sensitivity to imidazole antifungal agents or to any ingredient of the study medication

4.Subjects taking any other form of alternative treatment like ayurvedic etc.. for fungal infections

5.Subjects known to have hypersensitivity to any of the ingredients of the formulation

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To evaluate the efficacyof ketoconazole 2 % in combination with Beclomethasone 0.025% ointment in preventing the Tinea InfectionsTimepoint: 2 Weeks form base line
Secondary Outcome Measures
NameTimeMethod
To evaluate the safety and tolerability of ketoconazole 2 % in combinaton with Beclomethasone 0.025% cream based on the adverse effects as mentioned by the patientTimepoint: total 4 week <br/ ><br> <br/ ><br>2 weeks study follow up <br/ ><br>2 weeks Telephonic follow up
© Copyright 2025. All Rights Reserved by MedPath